What does OS Therapies Incorporated do?
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and…
What is OS Therapies Incorporated's P/E and P/B ratio?
OS Therapies Incorporated has a P/E ratio of -1.2 and a P/B ratio of -4.91.
What is OS Therapies Incorporated's debt-to-equity ratio?
OS Therapies Incorporated has a debt-to-equity ratio of 0.00.
How much does OS Therapies Incorporated owe compared with what it owns?
OS Therapies Incorporated owes $2.20 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is OS Therapies Incorporated's Positivity rank?
OS Therapies Incorporated is ranked #6,473 of 6,774 companies globally and #3,726 of 4,000 in United States on PositoAI, with a Positivity Score of -20,589.
Does OS Therapies Incorporated have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
OS Therapies Incorporated has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Quarterly report filed late (NT 10-Q).
Where can I read the latest news about OS Therapies Incorporated?
Recent headlines about OS Therapies Incorporated from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does OS Therapies Incorporated have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of OS Therapies Incorporated's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.